These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 805187)

  • 21. WHO activities towards the three Rs in the development and control of biological products.
    Milstien J; Grachev V; Padilla A; Griffiths E
    Dev Biol Stand; 1996; 86():31-9. PubMed ID: 8785961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring vaccines for human oncogenicity.
    Miller RW
    Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436
    [No Abstract]   [Full Text] [Related]  

  • 23. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA; Nasibov MN; Jakovleva NV
    Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endotoxic contamination of biological products (ribosomal vaccines, viral vaccines and interferon)].
    Fumarola D; Panaro A; Palma R; Mazzone A
    G Batteriol Virol Immunol; 1979; 72(1-6):72-7. PubMed ID: 95449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adventitious agents in viral vaccines: lessons learned from 4 case studies.
    Petricciani J; Sheets R; Griffiths E; Knezevic I
    Biologicals; 2014 Sep; 42(5):223-36. PubMed ID: 25135887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits, risks and costs of viral vaccines.
    Koplan JP; Axnick NW
    Prog Med Virol; 1982; 28():180-91. PubMed ID: 6806868
    [No Abstract]   [Full Text] [Related]  

  • 27. A field with a liver measles-mumps-rubella vaccine.
    Walters VW; Miller SA; Jackson JE; Kenny MT
    Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of bacteriophages from commercial sera.
    Merril CR; Friedman TB; Attallah AF; Geier MR; Krell K; Yarkin R
    In Vitro; 1972; 8(2):91-3. PubMed ID: 4567658
    [No Abstract]   [Full Text] [Related]  

  • 29. [What is the present status of the common virus vaccines?].
    Regnard J
    Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunizing agents: potential for controlling or eradicating infectious diseases.
    Wehrle PF; Wilkins J
    Annu Rev Public Health; 1981; 2():363-95. PubMed ID: 7348557
    [No Abstract]   [Full Text] [Related]  

  • 31. Viral vaccines in historical perspective.
    Hilleman MR
    Dev Biol Stand; 1995; 84():107-16. PubMed ID: 7796942
    [No Abstract]   [Full Text] [Related]  

  • 32. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriophage contamination in calf sera collected by different methods from various sources.
    Vieu JF; Horodniceanu F; Klein B; Lehérissey M
    J Biol Stand; 1978 Oct; 6(4):261-6. PubMed ID: 755822
    [No Abstract]   [Full Text] [Related]  

  • 35. Markers and vaccines.
    Kańtoch M
    Adv Virus Res; 1978; 22():259-325. PubMed ID: 76436
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 38. Recommendation of the Public Health Service Advisory Committee on Immunization Practices. Combination live virus vaccines: measles and rubella measles, mumps and rubella.
    J Kans Med Soc; 1971 Oct; 72(10):428 passim. PubMed ID: 5109988
    [No Abstract]   [Full Text] [Related]  

  • 39. Viral vaccines: various cell substrates and long-term prospective studies.
    Kirschstein RL; Petricciani JC
    Adv Exp Med Biol; 1972; 31(0):197-206. PubMed ID: 4212515
    [No Abstract]   [Full Text] [Related]  

  • 40. Appraisal and reappraisal of viral vaccines.
    Meyer HM; Hopps HE; Parkman PD
    Adv Intern Med; 1980; 25():533-60. PubMed ID: 6987851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.